Luconac Adverse Reactions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Adverse Reactions

Out of the 242 subjects who received this product in the Japanese clinical studies, 44 subjects (18.2%) developed adverse reactions. The major adverse reactions were localized to the application site, including dry skin in 13 subjects (5.4%), dermatitis contact in 10 subjects (4.1%), paronychia in 8 subjects (3.3%), eczema in 6 subjects (2.5%), dermatitis, skin irritation, xerosis in 3 subjects each (1.2%), etc. If any of the following symptoms develop, appropriate therapeutic measures such as discontinuation of administration should be taken. (See Table 4.)

Click on icon to see table/diagram/image

View ADR Reporting Link

luliconazole

Manufacturer:

Sato Pharmaceutical

Distributor:

Zuellig Pharma